Stocks and Investing Stocks and Investing
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023

Richard Newitter Maintained (TMCI) at Strong Buy with Increased Target to $16 on, Dec 22nd, 2023


Published on 2024-10-28 08:07:03 - WOPRAI, Richard Newitter
  Print publication without navigation


Richard Newitter of Truist Securities, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $12 to $16 on, Dec 22nd, 2023.

Richard has made no other calls on TMCI in the last 4 months.



There are 5 other peers that have a rating on TMCI. Out of the 5 peers that are also analyzing TMCI, 1 agrees with Richard's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Reiterated at Hold and Held Target at $25 on, Tuesday, September 12th, 2023


These are the ratings of the 4 analyists that currently disagree with Richard


  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $14 on, Monday, November 13th, 2023
  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $11 on, Friday, November 10th, 2023
  • Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $24 on, Friday, September 29th, 2023
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, August 28th, 2023